RNF43 and cancer: The results confirmed that RNF43 expression was significantly correlated with the sensitivity of several anti-cancer agents, such as cisplatin, fluorouracil, and lenvatinib, suggesting the potential of RNF43 in predicting the chemotherapy and targeted therapy responses in cancer patients.